Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Epidemiol ; 66(1): 62-6, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23177895

ABSTRACT

OBJECTIVES: To determine primarily (1) the incidence of ventilator-associated pneumonia (VAP) among ventilated patients aged 1 month to 12 years and secondarily (2) the risk factors for VAP and (3) common organisms causing VAP. STUDY DESIGN AND SETTING: Prospective study in a tertiary care center in India. Consecutive ventilated patients aged ≥1 month and ≤12 years and requiring mechanical ventilation (MV) for ≥48 hours were included after written informed parental consent. For the diagnosis of VAP, National Nosocomial Infections Surveillance System criteria of 1996 were used. RESULTS: Incidence of VAP among patients aged 1 month to 12 years was 36.2% (38/105; 95% confidence interval [CI]: 27, 46). In unconditional logistic regression analysis controlling for the presence of underlying illnesses, risk factor for VAP was >4 days of MV (adjusted odds ratio, 3.76; 95% CI: 1.41, 10.02; P = 0.008). Reintubation within 72 hours of extubation and more than two attendants at the time of recruitment showed increased tendency for the development of VAP but did not reach statistical significance. Endotracheal and endobronchial aspirates were positive for organism in 19.05% (20/105) and 37.14% (39/105) of patients, respectively. CONCLUSION: Almost one-third of ventilated patients develop VAP. Vigilance for the development of VAP has to be kept on those requiring >4 days of MV. Klebsiella and Staphylococcus aureus were common bacterial isolates in such patients.


Subject(s)
Pneumonia, Ventilator-Associated/etiology , Respiration, Artificial/adverse effects , Child , Child, Preschool , Female , Humans , Incidence , Infant , Infant, Newborn , Klebsiella Infections/epidemiology , Klebsiella Infections/etiology , Klebsiella Infections/microbiology , Logistic Models , Male , Pneumonia, Staphylococcal/epidemiology , Pneumonia, Staphylococcal/etiology , Pneumonia, Staphylococcal/microbiology , Pneumonia, Ventilator-Associated/epidemiology , Pneumonia, Ventilator-Associated/microbiology , Prospective Studies , Respiration, Artificial/statistics & numerical data
2.
BMJ Case Rep ; 20122012 Aug 01.
Article in English | MEDLINE | ID: mdl-22854238

ABSTRACT

A male term neonate, at day 23 of life, presented with vesicular lesions over the trunk, which spread to allover the body on the next day. Five days later, he started developing blistering of the skin over the trunk and extremities, which subsequently ruptured, leaving erythematous, tender raw areas with peeling of the skin. The mother had vesicular eruptions, which started on the second day of delivery and progressed over the next 3 days. Subsequently, similar eruptions were noticed in two of the siblings before affecting the neonate. On the basis of the exposure history and clinical picture, a diagnosis was made of varicella infection with staphylococcal scalded skin syndrome (SSSS). The blood culture and the wound surface culture grew Staphylococcus aureus. Treatment included intravenous fluid, antibiotics, acyclovir and wound care. However, after 72 h of hospitalisation, the neonate first developed shock, refractory to fluid boluses, vasopressors and catecholamine along with other supports; and he then succumbed. In all neonates, staphylococcal infection with varicella can be fatal due to SSSS, the toxic shock syndrome or septicaemia.


Subject(s)
Chickenpox/complications , Shock, Septic/etiology , Skin/pathology , Staphylococcal Scalded Skin Syndrome/complications , Staphylococcus aureus/isolation & purification , Acyclovir/therapeutic use , Adult , Anti-Bacterial Agents/therapeutic use , Antiviral Agents/therapeutic use , Chickenpox/drug therapy , Chickenpox/pathology , Fatal Outcome , Female , Humans , Infant , Infant, Newborn , Male , Mothers , Shock, Septic/microbiology , Shock, Septic/pathology , Shock, Septic/virology , Staphylococcal Scalded Skin Syndrome/drug therapy , Staphylococcal Scalded Skin Syndrome/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...